The U.S. Food and Drug Administration (FDA) granted market clearance for GE Healthcare’s MAGiC (MAGnetic resonance image Compilation) software, the industry’s first multi-contrast magnetic resonance imaging (MRI) technique that delivers eight contrasts in a single acquisition in fraction of the time of conventional imaging. MAGiC is the result of a collaboration with SyntheticMR AB and gives clinicians more data than conventional scanning.
You are here: / / / Conditional FDA Clearance for Certain MRIs On MAGEC Patients
This site uses Akismet to reduce spam. Learn how your comment data is processed.